ArticleFrontiers in pharmacology2021

Ropivacaine Inhibits Lung Cancer Cell Malignancy Through Downregulation of Cellular Signaling Including HIF-1α

Junmei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.